Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With Type 2 Diabetes and COVID-19 in Morocco?
Bouchra Benfathallah, Abha Cherkani Hassani, Samia El Hilali, Redouane Abouqal, Laïla Benchekroun
Cureus, doi:10.7759/cureus.77288
Objectives: To assess whether metformin therapy for type 2 diabetes (T2DM) was associated with a reduced mortality rate in patients hospitalized for COVID-19 compared to other antihyperglycemic drugs. Methods: This retrospective study included patients with T2DM who tested positive for SARS-CoV-2 between 1 August 2020 and 1 August 2021. The patients were required to be aged over 18 years old and to be undergoing treatment for hyperglycemia, whether with metformin, other oral antidiabetic drugs, or insulin. A data exploitation sheet was completed for each patient. The Jamovi ( https://www.jamovi.org/ ) software was applied to conduct the statistical analyses. Multivariate logistic regression was used to determine whether metformin use was associated with reduced mortality among patients with T2DM and COVID-19. Results: We identified 115 COVID-19 patients with T2DM, of whom 41 were on metformin, 35 patients were on insulin, and 39 patients were on other oral antihyperglycemic agents; the average age of patients was 65.5±13.2 years, and 52.2% were male. The mortality rate was lower in the metformin user group (21.1%) compared to the non-user group (78.9%). The multivariate logistic regression model indicated that age (OR=1.06; 95% CI (1.02-1.10); p=0.002) and glycemia (OR=1.49; 95% CI (1.05-2.11); p=0.024) were significantly associated with mortality in patients with T2DM and COVID-19. Whereas, the use of metformin was identified as a protective factor (OR=0.34 95% CI (0.12-0.95); p=0.041). Conclusion: This study highlighted that metformin seems to be associated with significantly decreased mortality in adults with T2DM and COVID-19.
Additional Information Author Contributions All authors have reviewed the final version to be published and agreed to be accountable for all aspects of the work. Concept and design: Bouchra Benfathallah, Abha Cherkani Hassani , Redouane Abouqal, Laïla Benchekroun Acquisition, analysis, or interpretation of data: Bouchra Benfathallah, Abha Cherkani Hassani , Samia El Hilali, Redouane Abouqal, Laïla Benchekroun Drafting of the manuscript: Bouchra Benfathallah, Laïla Benchekroun Critical review of the manuscript for important intellectual content: Bouchra Benfathallah, Abha Cherkani Hassani , Samia El Hilali, Redouane Abouqal, Laïla Benchekroun Supervision: Bouchra Benfathallah, Abha Cherkani Hassani , Samia El Hilali, Redouane Abouqal, Laïla Benchekroun
Disclosures Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. The Ethics Committee of Biomedical Research (CERB) issued approval N/R: Dossier n°L/21. Data access and patient anonymity were respected according to national and international guidelines. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they..
References
Bornstein, Rubino, Khunti, Practical recommendations for the management of diabetes in patients with COVID-19, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30152-2
Bramante, Huling, Tignanelli, Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19, N Engl J Med,
doi:10.1056/NEJMoa2201662
Bramante, Ingraham, Murray, Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis, Lancet Healthy Longev,
doi:10.1016/S2666-7568(20)30033-7
Cao, Baranova, Wei, Wang, Zhang, Bidirectional causal associations between type 2 diabetes and COVID-19, J Med Virol,
doi:10.1002/jmv.28100
Cao, Li, Tao, Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway, Endocrinol,
doi:10.1210/en.2013-1002
Cheng, Xin, Chen, Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: a multicentral retrospective study, Life Sci,
doi:10.1016/j.lfs.2021.119371
Erickson, Fenno, Barzilai, Metformin for treatment of acute COVID-19: systematic review of clinical trial data against SARS-CoV-2, Diabetes Care,
doi:10.2337/dc22-2539
Fang, Karakiulakis, Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med,
doi:10.1016/S2213-2600(20)30116-8
Gallo Marin, Aghagoli, Lavine, Predictors of COVID-19 severity: a literature review, Rev Med Virol,
doi:10.1002/rmv.2146
Gao, Liu, Zhong, Liu, Zhou et al., Risk of metformin in patients with type 2 diabetes with COVID-19: a preliminary retrospective report, Clin Transl Sci,
doi:10.1111/cts.12897
Ghany, Palacio, Dawkins, Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2021.02.022
Hariyanto, Kurniawan, Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection, Obes Med,
doi:10.1016/j.obmed.2020.100290
Holman, Knighton, Kar, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30271-0
Kaneto, Kimura, Obata, Shimoda, Kaku, Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history, Int J Mol Sci,
doi:10.3390/ijms22052596
Lalau, Al-Salameh, Hadjadj, Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19, Diabetes Metab,
doi:10.1016/j.diabet.2020.101216
Li, Yang, Yan, Sun, Zeng et al., Metformin in patients with COVID-19: a systematic review and meta-analysis, Front Med,
doi:10.3389/fmed.2021.704666
Lukito, Pranata, Henrina, Lim, Lawrensia et al., The effect of metformin consumption on mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.11.006
Luo, Qiu, Liu, Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis, Am J Trop Med Hyg,
doi:10.4269/ajtmh.20-0375
Ma, Krishnamurthy, Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis, PLoS One,
doi:10.1371/journal.pone.0282210
Malhotra, Hepokoski, Mccowen, Shyy, ACE2, metformin, and COVID-19, Iscience
Samuel, Varghese, Büsselberg, Therapeutic potential of metformin in COVID-19: reasoning for its protective role, Trends Microbiol,
doi:10.1016/j.tim.2021.03.004
Silverii, Fumagalli, Rozzini, Milani, Mannucci et al., Is metformin use associated with a more favorable Covid-19 course in people with diabetes?, J Clin Med,
doi:10.3390/jcm13071874
Singh, Singh, Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?, Diabetes Res Clin Pract,
doi:10.1016/j.diabres.2020.108268
Tong, Grant, Gras, The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes, FEBS J,
doi:10.1111/febs.16105
Wang, Cooper, Gokhale, Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes, J Clin Endocrinol Metab,
doi:10.1210/clinem/dgab067
Wang, Lin, Sy, Renal protective effect of metformin in type 2 diabetes patients, J Clin Endocrinol Metab,
doi:10.1210/clinem/dgae477
Watson, Dhaliwal, Robertshaw, Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process, Am J Kidney Dis,
doi:10.1053/j.ajkd.2022.10.012
Wiernsperger, Al-Salameh, Cariou, Lalau, Protection by metformin against severe COVID-19: an in-depth mechanistic analysis, Diabetes Metab,
doi:10.1016/j.diabet.2022.101359
{ 'indexed': { 'date-parts': [[2025, 1, 12]],
'date-time': '2025-01-12T05:21:46Z',
'timestamp': 1736659306657,
'version': '3.32.0'},
'reference-count': 31,
'publisher': 'Springer Science and Business Media LLC',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2025, 1, 11]]},
'DOI': '10.7759/cureus.77288',
'type': 'journal-article',
'created': {'date-parts': [[2025, 1, 11]], 'date-time': '2025-01-11T17:55:46Z', 'timestamp': 1736618146000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With '
'Type 2 Diabetes and COVID-19 in Morocco?',
'prefix': '10.7759',
'author': [ {'given': 'Bouchra', 'family': 'Benfathallah', 'sequence': 'first', 'affiliation': []},
{'given': 'Abha', 'family': 'Cherkani Hassani', 'sequence': 'additional', 'affiliation': []},
{'given': 'Samia', 'family': 'El Hilali', 'sequence': 'additional', 'affiliation': []},
{'given': 'Redouane', 'family': 'Abouqal', 'sequence': 'additional', 'affiliation': []},
{'given': 'Laïla', 'family': 'Benchekroun', 'sequence': 'additional', 'affiliation': []}],
'member': '297',
'reference': [ { 'key': 'ref1',
'doi-asserted-by': 'publisher',
'DOI': '10.1111/febs.16105',
'article-title': 'The role of T-cell immunity in COVID-19 severity amongst people living '
'with type II diabetes',
'volume': '288',
'author': 'Tong ZW',
'year': '2021',
'unstructured': 'Tong ZW, Grant E, Gras S, et al.. The role of T-cell immunity in '
'COVID-19 severity amongst people living with type II diabetes. FEBS J. '
'2021, 288:5042-54. 10.1111/febs.16105',
'journal-title': 'FEBS J'},
{ 'key': 'ref2',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S2213-8587(20)30271-0',
'article-title': 'Risk factors for COVID-19-related mortality in people with type 1 and '
'type 2 diabetes in England: a population-based cohort study',
'volume': '8',
'author': 'Holman N',
'year': '2020',
'unstructured': 'Holman N, Knighton P, Kar P, et al.. Risk factors for COVID-19-related '
'mortality in people with type 1 and type 2 diabetes in England: a '
'population-based cohort study. Lancet Diabetes Endocrinol. 2020, '
'8:823-33. 10.1016/S2213-8587(20)30271-0',
'journal-title': 'Lancet Diabetes Endocrinol'},
{ 'key': 'ref3',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S2213-2600(20)30116-8',
'article-title': 'Are patients with hypertension and diabetes mellitus at increased risk '
'for COVID-19 infection?',
'volume': '8',
'author': 'Fang L',
'year': '2020',
'unstructured': 'Fang L, Karakiulakis G, Roth M. Are patients with hypertension and '
'diabetes mellitus at increased risk for COVID-19 infection?. Lancet '
'Respir Med. 2020, 8:e21. 10.1016/S2213-2600(20)30116-8',
'journal-title': 'Lancet Respir Med'},
{ 'key': 'ref4',
'doi-asserted-by': 'publisher',
'DOI': '10.1002/jmv.28100',
'article-title': 'Bidirectional causal associations between type 2 diabetes and COVID-19',
'volume': '95',
'author': 'Cao H',
'year': '2023',
'unstructured': 'Cao H, Baranova A, Wei X, Wang C, Zhang F. Bidirectional causal '
'associations between type 2 diabetes and COVID-19. J Med Virol. 2023, '
'95:e28100. 10.1002/jmv.28100',
'journal-title': 'J Med Virol'},
{ 'key': 'ref5',
'doi-asserted-by': 'publisher',
'DOI': '10.1210/clinem/dgab067',
'article-title': 'Association of metformin with susceptibility to COVID-19 in people with '
'type 2 diabetes',
'volume': '106',
'author': 'Wang J',
'year': '2021',
'unstructured': 'Wang J, Cooper JM, Gokhale K, et al.. Association of metformin with '
'susceptibility to COVID-19 in people with type 2 diabetes. J Clin '
'Endocrinol Metab. 2021, 106:1255-68. 10.1210/clinem/dgab067',
'journal-title': 'J Clin Endocrinol Metab'},
{ 'key': 'ref6',
'doi-asserted-by': 'publisher',
'DOI': '10.3390/jcm13071874',
'article-title': 'Is metformin use associated with a more favorable Covid-19 course in '
'people with diabetes?',
'volume': '13',
'author': 'Silverii GA',
'year': '2024',
'unstructured': 'Silverii GA, Fumagalli C, Rozzini R, Milani M, Mannucci E, Marchionni N. '
'Is metformin use associated with a more favorable Covid-19 course in '
'people with diabetes?. J Clin Med. 2024, 13:1874. 10.3390/jcm13071874',
'journal-title': 'J Clin Med'},
{ 'key': 'ref7',
'doi-asserted-by': 'publisher',
'DOI': '10.2337/dc22-2539',
'article-title': 'Metformin for treatment of acute COVID-19: systematic review of '
'clinical trial data against SARS-CoV-2',
'volume': '46',
'author': 'Erickson SM',
'year': '2023',
'unstructured': 'Erickson SM, Fenno SL, Barzilai N, et al.. Metformin for treatment of '
'acute COVID-19: systematic review of clinical trial data against '
'SARS-CoV-2. Diabetes Care. 2023, 46:1432-42. 10.2337/dc22-2539',
'journal-title': 'Diabetes Care'},
{ 'key': 'ref8',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S2666-7568(20)30033-7',
'article-title': 'Metformin and risk of mortality in patients hospitalised with COVID-19: '
'a retrospective cohort analysis',
'volume': '2',
'author': 'Bramante CT',
'year': '2021',
'unstructured': 'Bramante CT, Ingraham NE, Murray TA, et al.. Metformin and risk of '
'mortality in patients hospitalised with COVID-19: a retrospective cohort '
'analysis. Lancet Healthy Longev. 2021, 2:e34-41. '
'10.1016/S2666-7568(20)30033-7',
'journal-title': 'Lancet Healthy Longev'},
{ 'key': 'ref9',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0282210',
'article-title': 'Is metformin use associated with low mortality in patients with type 2 '
'diabetes mellitus hospitalized for COVID-19? a multivariable and '
'propensity score-adjusted meta-analysis',
'volume': '18',
'author': 'Ma Z',
'year': '2023',
'unstructured': 'Ma Z, Krishnamurthy M. Is metformin use associated with low mortality in '
'patients with type 2 diabetes mellitus hospitalized for COVID-19? a '
'multivariable and propensity score-adjusted meta-analysis. PLoS One. '
'2023, 18:e0282210. 10.1371/journal.pone.0282210',
'journal-title': 'PLoS One'},
{ 'key': 'ref10',
'doi-asserted-by': 'publisher',
'DOI': '10.3389/fmed.2021.704666',
'article-title': 'Metformin in patients with COVID-19: a systematic review and '
'meta-analysis',
'volume': '8',
'author': 'Li Y',
'year': '2021',
'unstructured': 'Li Y, Yang X, Yan P, Sun T, Zeng Z, Li S. Metformin in patients with '
'COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). '
'2021, 8:704666. 10.3389/fmed.2021.704666',
'journal-title': 'Front Med (Lausanne)'},
{ 'key': 'ref11',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.diabet.2020.101216',
'article-title': 'Metformin use is associated with a reduced risk of mortality in '
'patients with diabetes hospitalised for COVID-19',
'volume': '47',
'author': 'Lalau JD',
'year': '2021',
'unstructured': 'Lalau JD, Al-Salameh A, Hadjadj S, et al.. Metformin use is associated '
'with a reduced risk of mortality in patients with diabetes hospitalised '
'for COVID-19. Diabetes Metab. 2021, 47:101216. '
'10.1016/j.diabet.2020.101216',
'journal-title': 'Diabetes Metab'},
{ 'key': 'ref12',
'doi-asserted-by': 'publisher',
'DOI': '10.4269/ajtmh.20-0375',
'article-title': 'Metformin treatment was associated with decreased mortality in COVID-19 '
'patients with diabetes in a retrospective analysis',
'volume': '103',
'author': 'Luo P',
'year': '2020',
'unstructured': 'Luo P, Qiu L, Liu Y, et al.. Metformin treatment was associated with '
'decreased mortality in COVID-19 patients with diabetes in a '
'retrospective analysis. Am J Trop Med Hyg. 2020, 103:69-72. '
'10.4269/ajtmh.20-0375',
'journal-title': 'Am J Trop Med Hyg'},
{ 'key': 'ref13',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.lfs.2021.119371',
'article-title': 'Effects of metformin, insulin on COVID-19 patients with pre-existed '
'type 2 diabetes: a multicentral retrospective study',
'volume': '275',
'author': 'Cheng X',
'year': '2021',
'unstructured': 'Cheng X, Xin S, Chen Y, et al.. Effects of metformin, insulin on '
'COVID-19 patients with pre-existed type 2 diabetes: a multicentral '
'retrospective study. Life Sci. 2021, 275:119371. '
'10.1016/j.lfs.2021.119371',
'journal-title': 'Life Sci'},
{ 'key': 'ref14',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S2213-8587(20)30152-2',
'article-title': 'Practical recommendations for the management of diabetes in patients '
'with COVID-19',
'volume': '8',
'author': 'Bornstein SR',
'year': '2020',
'unstructured': 'Bornstein SR, Rubino F, Khunti K, et al.. Practical recommendations for '
'the management of diabetes in patients with COVID-19. Lancet Diabetes '
'Endocrinol. 2020, 8:546-50. 10.1016/S2213-8587(20)30152-2',
'journal-title': 'Lancet Diabetes Endocrinol'},
{ 'key': 'ref15',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.diabres.2020.108268',
'article-title': 'Is metformin ahead in the race as a repurposed host-directed therapy '
'for patients with diabetes and COVID-19?',
'volume': '165',
'author': 'Singh AK',
'year': '2020',
'unstructured': 'Singh AK, Singh R. Is metformin ahead in the race as a repurposed '
'host-directed therapy for patients with diabetes and COVID-19?. Diabetes '
'Res Clin Pract. 2020, 165:108268. 10.1016/j.diabres.2020.108268',
'journal-title': 'Diabetes Res Clin Pract'},
{ 'key': 'ref16',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.diabres.2020.108183',
'article-title': 'Metformin in COVID-19: a possible role beyond diabetes',
'volume': '164',
'author': 'Sharma S',
'year': '2020',
'unstructured': 'Sharma S, Ray A, Sadasivam B. Metformin in COVID-19: a possible role '
'beyond diabetes. Diabetes Res Clin Pract. 2020, 164:108183. '
'10.1016/j.diabres.2020.108183',
'journal-title': 'Diabetes Res Clin Pract'},
{ 'key': 'ref17',
'doi-asserted-by': 'publisher',
'DOI': '10.1002/rmv.2146',
'article-title': 'Predictors of COVID-19 severity: a literature review',
'volume': '31',
'author': 'Gallo Marin B',
'year': '2021',
'unstructured': 'Gallo Marin B, Aghagoli G, Lavine K, et al.. Predictors of COVID-19 '
'severity: a literature review. Rev Med Virol. 2021, 31:1-10. '
'10.1002/rmv.2146',
'journal-title': 'Rev Med Virol'},
{ 'key': 'ref18',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.tim.2021.03.004',
'article-title': 'Therapeutic potential of metformin in COVID-19: reasoning for its '
'protective role',
'volume': '29',
'author': 'Samuel SM',
'year': '2021',
'unstructured': 'Samuel SM, Varghese E, Büsselberg D. Therapeutic potential of metformin '
'in COVID-19: reasoning for its protective role. Trends Microbiol. 2021, '
'29:894-907. 10.1016/j.tim.2021.03.004',
'journal-title': 'Trends Microbiol'},
{ 'key': 'ref19',
'doi-asserted-by': 'publisher',
'DOI': '10.1210/clinem/dgae477',
'article-title': 'Renal protective effect of metformin in type 2 diabetes patients',
'author': 'Wang HH',
'year': '2024',
'unstructured': 'Wang HH, Lin SH, Hung SY, et al.. Renal protective effect of metformin '
'in type 2 diabetes patients. J Clin Endocrinol Metab. 2024, 477. '
'10.1210/clinem/dgae477',
'journal-title': 'J Clin Endocrinol Metab'},
{ 'key': 'ref20',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.biopha.2021.111454',
'article-title': 'Mechanism and application of metformin in kidney diseases: an update',
'volume': '138',
'author': 'Song A',
'year': '2021',
'unstructured': 'Song A, Zhang C, Meng X. Mechanism and application of metformin in '
'kidney diseases: an update. Biomed Pharmacother. 2021, 138:111454. '
'10.1016/j.biopha.2021.111454',
'journal-title': 'Biomed Pharmacother'},
{ 'key': 'ref21',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.dsx.2020.11.006',
'article-title': 'The effect of metformin consumption on mortality in hospitalized '
'COVID-19 patients: a systematic review and meta-analysis',
'volume': '14',
'author': 'Lukito AA',
'year': '2020',
'unstructured': 'Lukito AA, Pranata R, Henrina J, Lim MA, Lawrensia S, Suastika K. The '
'effect of metformin consumption on mortality in hospitalized COVID-19 '
'patients: a systematic review and meta-analysis. Diabetes Metab Syndr. '
'2020, 14:2177-83. 10.1016/j.dsx.2020.11.006',
'journal-title': 'Diabetes Metab Syndr'},
{ 'key': 'ref22',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.dsx.2021.02.022',
'article-title': 'Metformin is associated with lower hospitalizations, mortality and '
'severe coronavirus infection among elderly medicare minority patients '
'in 8 states in USA',
'volume': '15',
'author': 'Ghany R',
'year': '2021',
'unstructured': 'Ghany R, Palacio A, Dawkins E, et al.. Metformin is associated with '
'lower hospitalizations, mortality and severe coronavirus infection among '
'elderly medicare minority patients in 8 states in USA. Diabetes Metab '
'Syndr. 2021, 15:513-8. 10.1016/j.dsx.2021.02.022',
'journal-title': 'Diabetes Metab Syndr'},
{ 'key': 'ref23',
'doi-asserted-by': 'publisher',
'DOI': '10.1111/cts.12897',
'article-title': 'Risk of metformin in patients with type 2 diabetes with COVID-19: a '
'preliminary retrospective report',
'volume': '13',
'author': 'Gao Y',
'year': '2020',
'unstructured': 'Gao Y, Liu T, Zhong W, Liu R, Zhou H, Huang W, Zhang W. Risk of '
'metformin in patients with type 2 diabetes with COVID-19: a preliminary '
'retrospective report. Clin Transl Sci. 2020, 13:1055-9. '
'10.1111/cts.12897',
'journal-title': 'Clin Transl Sci'},
{ 'key': 'ref24',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2201662',
'article-title': 'Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19',
'volume': '387',
'author': 'Bramante CT',
'year': '2022',
'unstructured': 'Bramante CT, Huling JD, Tignanelli CJ, et al.. Randomized trial of '
'metformin, ivermectin, and fluvoxamine for COVID-19. N Engl J Med. 2022, '
'387:599-610. 10.1056/NEJMoa2201662',
'journal-title': 'N Engl J Med'},
{ 'key': 'ref25',
'doi-asserted-by': 'publisher',
'DOI': '10.1053/j.ajkd.2022.10.012',
'article-title': 'Consensus recommendations for sick day medication guidance for people '
'with diabetes, kidney, or cardiovascular disease: a modified Delphi '
'process',
'volume': '81',
'author': 'Watson KE',
'year': '2023',
'unstructured': 'Watson KE, Dhaliwal K, Robertshaw S, et al.. Consensus recommendations '
'for sick day medication guidance for people with diabetes, kidney, or '
'cardiovascular disease: a modified Delphi process. Am J Kidney Dis. '
'2023, 81:564-74. 10.1053/j.ajkd.2022.10.012',
'journal-title': 'Am J Kidney Dis'},
{ 'key': 'ref26',
'doi-asserted-by': 'crossref',
'DOI': '10.1016/j.isci.2020.101425',
'article-title': 'ACE2, metformin, and COVID-19',
'volume': '23',
'author': 'Malhotra A',
'year': '2020',
'unstructured': 'Malhotra A, Hepokoski M, McCowen KC, Shyy JY. ACE2, metformin, and '
'COVID-19. Iscience. 2020, 23:',
'journal-title': 'Iscience'},
{ 'key': 'ref27',
'doi-asserted-by': 'publisher',
'DOI': '10.3390/ijms22052596',
'article-title': 'Multifaceted mechanisms of action of metformin which have been '
'unraveled one after another in the long history',
'volume': '22',
'author': 'Kaneto H',
'year': '2021',
'unstructured': 'Kaneto H, Kimura T, Obata A, Shimoda M, Kaku K. Multifaceted mechanisms '
'of action of metformin which have been unraveled one after another in '
'the long history. Int J Mol Sci. 2021, 22:2596. 10.3390/ijms22052596',
'journal-title': 'Int J Mol Sci'},
{ 'key': 'ref28',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.obmed.2020.100290',
'article-title': 'Metformin use is associated with reduced mortality rate from '
'coronavirus disease 2019 (COVID-19) infection',
'volume': '19',
'author': 'Hariyanto TI',
'year': '2020',
'unstructured': 'Hariyanto TI, Kurniawan A. Metformin use is associated with reduced '
'mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes '
'Med. 2020, 19:100290. 10.1016/j.obmed.2020.100290',
'journal-title': 'Obes Med'},
{ 'key': 'ref29',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.diabet.2022.101359',
'article-title': 'Protection by metformin against severe COVID-19: an in-depth '
'mechanistic analysis',
'volume': '48',
'author': 'Wiernsperger N',
'year': '2022',
'unstructured': 'Wiernsperger N, Al-Salameh A, Cariou B, Lalau JD. Protection by '
'metformin against severe COVID-19: an in-depth mechanistic analysis. '
'Diabetes Metab. 2022, 48:101359. 10.1016/j.diabet.2022.101359',
'journal-title': 'Diabetes Metab'},
{ 'key': 'ref30',
'doi-asserted-by': 'publisher',
'DOI': '10.1210/en.2013-1002',
'article-title': 'Metformin inhibits vascular calcification in female rat aortic smooth '
'muscle cells via the AMPK-eNOS-NO pathway',
'volume': '154',
'author': 'Cao X',
'year': '2013',
'unstructured': 'Cao X, Li H, Tao H, et al.. Metformin inhibits vascular calcification in '
'female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. '
'Endocrinol. 2013, 154:3680-9. 10.1210/en.2013-1002',
'journal-title': 'Endocrinol'},
{ 'key': 'ref31',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)30305-6',
'article-title': 'Reducing mortality from 2019-nCoV: host-directed therapies should be an '
'option',
'volume': '395',
'author': 'Zumla A',
'year': '2020',
'unstructured': 'Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from '
'2019-nCoV: host-directed therapies should be an option. Lancet. 2020, '
'395:e35-6. 10.1016/S0140-6736(20)30305-6',
'journal-title': 'Lancet'}],
'container-title': 'Cureus',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.cureus.com/articles/325967-does-the-consumption-of-metformin-correlate-with-a-reduction-in-mortality-among-patients-with-type-2-diabetes-and-covid-19-in-morocco',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2025, 1, 11]],
'date-time': '2025-01-11T17:55:48Z',
'timestamp': 1736618148000},
'score': 1,
'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/325967-does-the-consumption-of-metformin-correlate-with-a-reduction-in-mortality-among-patients-with-type-2-diabetes-and-covid-19-in-morocco'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2025, 1, 11]]},
'references-count': 31,
'URL': 'http://dx.doi.org/10.7759/cureus.77288',
'relation': {},
'ISSN': ['2168-8184'],
'subject': [],
'published': {'date-parts': [[2025, 1, 11]]}}